GlassScriptPhysician profile
Maryalice Ruth Case
NPI 1982310611
$2,646.52
in general payments reported to CMS, 2019-2025
14 companies · $1,164 in 2025
The $1,164 reported for 2025 was more than what 83% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,482 · 2025: $1,164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,527 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,526.58 |
| Education | $119.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $684.77 | 2024-2025 | |
| Teva Pharmaceuticals USA, INC. | $502.96 | 2024-2025 | Uzedy, Austedo Xr |
| Alkermes, INC. | $496.04 | 2024-2025 | Aristada, Lybalvi, Vivitrol |
| Janssen Pharmaceuticals, INC | $269.51 | 2024-2025 | Invega Sustenna |
| Otsuka America Pharmaceutical, INC. | $226.40 | 2024-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Neurocrine Biosciences, INC. | $163.00 | 2024-2025 | Ingrezza |
| Lundbeck LLC | $122.60 | 2024-2025 | Abilify Asimtufii |
| Novartis Pharmaceuticals Corporation | $40.32 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $35.31 | 2025 | Cobenfy |
| Indivior INC. | $31.60 | 2024 | Perseris |
| Braeburn INC. | $23.88 | 2024 | Brixadi |
| Abbott Laboratories | $18.28 | 2025 | Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $16.35 | 2024 | Auvelity |
| Bayer Healthcare Pharmaceuticals INC. | $15.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maryalice Case listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.